Molecular Partners AG
MOLN
$3.77
-$0.20-5.04%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -27.77% | -27.91% | -0.95% | -63.11% | -96.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -27.77% | -27.94% | -1.29% | -63.18% | -96.19% |
| Cost of Revenue | 1.26% | 9.72% | 13.58% | 10.32% | 1.61% |
| Gross Profit | -6.24% | -18.15% | -16.82% | -61.63% | -129.87% |
| SG&A Expenses | -6.06% | -4.26% | -7.69% | -8.42% | -6.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.92% | 5.46% | 6.84% | 4.30% | -1.01% |
| Operating Income | -2.16% | -10.32% | -7.97% | -30.43% | -153.19% |
| Income Before Tax | 11.10% | -9.44% | 1.11% | -25.63% | -153.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 11.09% | -9.44% | 1.11% | -25.63% | -153.42% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.09% | -9.44% | 1.11% | -25.63% | -153.42% |
| EBIT | -2.16% | -10.32% | -7.97% | -30.43% | -153.19% |
| EBITDA | -2.16% | -10.60% | -8.03% | -31.26% | -150.57% |
| EPS Basic | 13.84% | -8.32% | 2.07% | -24.44% | -152.57% |
| Normalized Basic EPS | 13.85% | -8.30% | 2.08% | -24.44% | -152.58% |
| EPS Diluted | 13.74% | -8.32% | 2.08% | -24.36% | -154.33% |
| Normalized Diluted EPS | 13.85% | -8.30% | 2.08% | -24.44% | -154.34% |
| Average Basic Shares Outstanding | 3.85% | 1.02% | 0.99% | 0.98% | 0.93% |
| Average Diluted Shares Outstanding | 3.85% | 1.02% | 0.99% | 0.98% | 0.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |